Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Medicine Greifswald
About this trial
Physical activity is an important aspect of cancer therapy but correct measurement of physical activity is difficult. In this study, the physical activity of patients undergoing cancer therapy is assessed by questionnaire and by motion tracker. The results are then compared to answer whether there are differences between the two measurements. Findings of this study will help to improve the assessment of physical activity in cancer patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
verified diagnosis of lymphoma, colorectal or pancreatic cancer
requirement of surgical, chemo or radio therapy
provision of informed consent
Disqualifiers
pregnancy
inability to provide consent
use of a rollator
Trial population
Patients will be recruited at University Medicine Greifswald (Northeast Germany). Patients with the verified diagnosis of lymphoma, colerectal or pancreatic cancer requiring surgical, chemo or radio therapy will be identified in the respective wards or day care units of the hosptial.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
No intervention - observational study only
Other interventionNo intervention - observational study only
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Cancer Patients1 intervention
Trial outcomes
Primary outcomes
1
Comparison of physical activity assessments within 1 week after initiation of cancer therapy
Difference in physical activity measured by the GeneActiv accelerometer and the short version of the International Physical Activity Questionnaire (IPAQ-sf) in metabolic equivalents of tasks (METs)
Time frame
1 week after initiation of cancer therapySecondary outcomes
1
Comparison of physical activity assessments 12 weeks after initiation of cancer therapy
Difference in physical activity measured by the GeneActiv accelerometer and the short version of the International Physical Activity Questionnaire (IPAQ-sf) in metabolic equivalents of tasks (METs)
Time frame
12 weeks after initiation of cancer therapy2
Comparison of changes in physical activity between assessements within 1 week and 12 weeks after initiation of cancer therapy
Difference in changes of physical activity measured by the GeneActiv accelerometer and the short version of the International Physical Activity Questionnaire (IPAQ-sf) in metabolic equivalents of tasks (METs)
Time frame
12 weeks after initiation of cancer therapy3
Physical activity assessed by accelerometer
Physical activity measured by the GeneActiv accelerometer in metabolic equivalents of tasks (METs)
Time frame
1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapy4
Physical activity assessed by questionnaire
Physical activity measured by the short version of the International Physical Activity Questionnaire (IPAQ-sf) in metabolic equivalents of tasks (METs)
Time frame
1 week before initiation of cancer therapy, 1 week after initiation of cancer therapy, 12 weeks after initiation of cancer therapySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov